MedTrace Logo

EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

NCT05029414 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 543

Last updated 2024-12-24

No results posted yet for this study

Summary

Acute ischemic stroke (AIS) is one of the main causes of disability and loss of quality adjusted life years. This study is to analyze whether endovascular therapy (EVT) in addition to best medical treatment (BMT) reduces the degree of disability and dependency in daily activities after a Medium Vessel Occlusion (MeVO) stroke compared to BMT alone.

Conditions

  • Acute Ischemic Stroke

Interventions

PROCEDURE

Endovascular Therapy

Endovascular treatment of stroke is the non-surgical treatment for the sudden loss of brain function due to blood clots. The blood clot is removed from the blood via devices (i.e. stent-retriever, aspiration catheters and balloon guide) to achieve revascularization.

Sponsors & Collaborators

  • Swiss National Fund for Scientific Research

    collaborator OTHER

  • Stryker Neurovascular

    collaborator INDUSTRY

  • Penumbra Inc.

    collaborator INDUSTRY

  • Medtronic

    collaborator INDUSTRY

  • Phenox GmbH

    collaborator INDUSTRY

  • Rapid Medical

    collaborator INDUSTRY

  • Gottfried und Julia Bangerter- Rhyner-Stiftung, Basel

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Marios-Nikos Psychogios, Prof.Dr. · Department of Interventional and Diagnostical Neuroradiology, University Hospital Basel

  • Urs Fischer, Prof.Dr. · Neurology, Inselspital, Bern University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-09
Primary Completion
2024-10-10
Completion
2025-06-01

Countries

  • Belgium
  • Finland
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05029414 on ClinicalTrials.gov